Literature DB >> 24833163

Normal functioning and the treatment/enhancement distinction: an opportunity based assessment.

Jonathan Huggins1, Mary Simmerling.   

Abstract

As genome mapping technology uncovers the roots of pathologic and physiologic human functioning, important questions are brought to the fore concerning our conceptualization of ideas such as disease, treatment, and enhancement. In 1985, Norman Daniels proposed a normal-functioning model that expands John Rawls' theory of justice to obligate the provision of health care based on the constraints disease places on individual opportunity, but also limits the commitment of the medical establishment by focusing on states that represent deviations from normal human function. While some argue that the boundaries of medical institutions' commitment to provide services within a normal-functioning model are arbitrary, the degree to which these concerns truly threaten the framework is often exaggerated in special cases put forward in the literature. Furthermore, the normal-functioning model provides a comprehensive basis for agreement in discussions of medicine's commitment to the demands of social justice where resources are limited and avoids the dangerous overextension of the healthcare system and medicalization to which more expansive models are exposed.

Entities:  

Mesh:

Year:  2014        PMID: 24833163     DOI: 10.1007/s10943-014-9882-7

Source DB:  PubMed          Journal:  J Relig Health        ISSN: 0022-4197


  6 in total

1.  Normal functioning and the treatment-enhancement distinction.

Authors:  N Daniels
Journal:  Camb Q Healthc Ethics       Date:  2000       Impact factor: 1.284

2.  Ethical issues in enhancement: an introduction.

Authors:  G McGee
Journal:  Camb Q Healthc Ethics       Date:  2000       Impact factor: 1.284

Review 3.  Justice, health, and healthcare.

Authors:  N Daniels
Journal:  Am J Bioeth       Date:  2001       Impact factor: 11.229

Review 4.  Egalitarianism and responsibility in the genetic future.

Authors:  Linda Barclay
Journal:  J Med Philos       Date:  2009-02-25

5.  Equality and the treatment-enhancement distinction.

Authors:  Nils Holtug
Journal:  Bioethics       Date:  2011-03       Impact factor: 1.898

Review 6.  Reflections on the ethics of genetic enhancement.

Authors:  Thomas H Murray
Journal:  Genet Med       Date:  2002 Nov-Dec       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.